InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Ryan Michael Charles, Executive. Director active across 1 company, notably Kiromic Biopharma, Inc.. Cumulatively, 2 disclosures have been published. Activity tracked since 13 July 2021. The latest transaction was disclosed on 13 July 2021 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
50,189 shares0Common StockSEC:0001104659-21-098784:0
50,189 shares0Common StockSEC:0001104659-21-098784
2 of 2 declarations
About Ryan Michael Charles
Ryan Michael Charles is an executive at Kiromic Biopharma, Inc. Although his specific functions are not mentioned, he plays an important role in the company's leadership. His expertise in the biopharmaceutical field and management experience are essential for the development and implementation of the company's strategies.
